05.12.26 -- What's Driving The Next Wave Of Biologic Innovation

A fireside chat focused on how integrated development models can meaningfully reduce risk and speed bioconjugate programs from discovery through GMP manufacturing.

Developing robust microbial fermentation depends on optimizing growth and expression phases through efficient oxygen transfer, fine-tuning of nutrient delivery, and induction of protein expression.

An event-focused overview examining how formulation development and stability strategies support robust, scalable drug products discussed at the DDF Summit Berlin.

End‑to‑end pharmaceutical contract manufacturing supporting development and commercial production across biologics, small molecules, advanced modalities, and drug products worldwide.

Integrated culture and fermentation systems streamline development, improve scalability, and strengthen continuity throughout the lifecycle of complex biopharmaceutical programs.

Discover how synthetic biology, advanced enzyme engineering, and global infrastructure accelerate biologic innovation through more efficient discovery, optimization, and development workflows.

Accelerate your biologics program with an integrated discovery‑to‑development partner built to deliver high‑quality candidates with speed and scientific rigor.

With proven expertise in process development, optimization, and CGMP manufacturing, Avid offers end-to-end CDMO solutions backed by flexible capacity designed to scale with program needs.

With a proven track record across numerous facility projects, our flexible, client-focused model ensures seamless integration with internal teams and third-party vendors, delivering high satisfaction and long-term partnerships.

By leveraging our proprietary non-viral gene insertion technology, GPEx® Lightning ensures rapid development timelines and high-yield production, making it an ideal solution for complex biologics.

In this interview, Dr. Michael Grass discusses how the company is adapting to emerging trends in the CDMO landscape, driving innovation, and enhancing pharmaceutical product development.

Delve into how advanced mRNA manufacturing innovations, including optimized RNA synthesis and scalable LNP encapsulation, are accelerating therapeutic development.